Avestar Capital’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.93M Buy
11,363
+1,299
+13% +$394K 0.28% 64
2026
Q1
$2.15M Sell
10,064
-425
-4% -$95K 0.14% 116
2025
Q4
$1.8M Buy
10,489
+657
+7% +$102K 0.12% 141
2025
Q3
$1.32M Buy
9,832
+992
+11% +$105K 0.09% 177
2025
Q2
$862K Buy
8,840
+1,305
+17% +$104K 0.06% 241
2025
Q1
$549K Sell
7,535
-701
-9% -$55.2K 0.05% 276
2024
Q4
$597K Buy
8,236
+326
+4% +$24.7K 0.05% 254
2024
Q3
$646K Buy
7,910
+840
+12% +$73K 0.07% 220
2024
Q2
$754K Buy
7,070
+460
+7% +$44.1K 0.08% 190
2024
Q1
$644K Buy
6,610
+1,260
+24% +$111K 0.07% 204
2023
Q4
$420K Buy
5,350
+2,090
+64% +$142K 0.05% 225
2023
Q3
$205K Buy
+3,260
New +$214K 0.03% 328
2019
Q3
Sell
-2,060
Closed -$38K 551
2019
Q2
$38K Hold
2,060
0.02% 327
2019
Q1
$36K Buy
2,060
+2,000
+3,333% +$33.4K 0.02% 321
2018
Q4
$0 Sell
60
-70
-54% -$1K ﹤0.01% 927
2018
Q3
$0 Buy
130
+40
+44% +$683 ﹤0.01% 932
2018
Q2
$1K Buy
90
+30
+50% +$578 ﹤0.01% 780
2018
Q1
$1K Hold
60
﹤0.01% 739
2017
Q4
$1K Buy
+60
New +$1.18K ﹤0.01% 707

Other funds holding LRCX

Avestar Capital's LRCX Position: Q2 2026 in Review

Avestar Capital increased its Lam Research (LRCX) stake by 13% in Q2 2026, buying an estimated $394K and bringing the position to 11,363 shares worth $4.93M. The position accounts for 0.28% of the portfolio, ranked #64.

Avestar Capital first reported a position in LRCX in Q4 2017 and has held it in 19 quarters since. 1,421 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Avestar Capital held 11,363 shares of Lam Research worth $4.93M as of Q2 2026.
  • Avestar Capital bought 1,299 Lam Research shares in Q2 2026, an estimated $394K.
  • Lam Research made up 0.28% of Avestar Capital's portfolio in Q2 2026, its #64 holding.
  • Avestar Capital first reported a position in Lam Research in Q4 2017 and has held it in 19 quarters since.
  • 1,421 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Avestar Capital's 13F filing for Q2 2026, filed 29 Jul 2026.